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Abstract. 
 
Death-associated protein (DAP)–kinase is a 
calcium/calmodulin regulated serine/threonine kinase 
that carries ankyrin repeats, a death domain, and is lo-
calized to the cytoskeleton. Here, we report that this ki-
nase is involved in tumor necrosis factor (TNF)-
 
a
 
 and 
Fas-induced apoptosis. Expression of DAP-kinase anti-
sense RNA protected cells from killing by anti–Fas/
APO-1 agonistic antibodies. Deletion of the death do-
main abrogated the apoptotic functions of the kinase, 
thus, documenting for the ﬁrst time the importance of 
this protein domain. Overexpression of a fragment en-
compassing the death domain of DAP-kinase acted as a 
speciﬁc dominant negative mutant that protected cells 
from TNF-
 
a
 
, Fas, and FADD/MORT1–induced cell 
death. DAP-kinase apoptotic function was blocked by 
bcl-2 as well as by crmA and p35 inhibitors of caspases, 
but not by the dominant negative mutants of FADD/
MORT1 or of caspase 8. Thus, it functions downstream 
to the receptor complex and upstream to other 
caspases. The multidomain structure of this serine/thre-
onine kinase, combined with its involvement in cell 
death induced by several different triggers, place DAP-
kinase at one of the central molecular pathways leading 
to apoptosis.
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A
 
POPTOSIS
 
 (programmed cell death) is an important
regulatory mechanism that eliminates unwanted
cells during development and maintenance of tis-
sue homeostasis. Over the past few years several apoptotic
genes have been identified. One approach consisted of the
isolation of proteins that are recruited to the intracellular
domains of cytokine receptors belonging to the tumor ne-
crosis factor (TNF)
 
1
 
 family. The yeast two-hybrid system
served as a major tool for the isolation of these cytoplas-
mic proteins that sequentially bind to the intracellular part
of TNF-
 
a
 
 receptor (p55 TNF-R), the Fas receptor, and to
each other. This includes a number of adaptor molecules
(TRADD, FADD/MORT-1, RAIDD, MADD, TRAF-1
or -2, and FLIP), proteins with enzymatic activity (RIP,
caspase 8 and 10, NIK), and death inhibitory molecules
(c-IAPs) (for review see Salvesen and Dixit, 1997; Cryns
and Yuan, 1998; Wallach et al., 1998). The interaction be-
tween these proteins is mediated by several structural mo-
tifs, i.e., the death domain (DD), the death effector do-
main (DED), and the caspase-recruiting domain (CARD).
Genetic screens performed in lower invertebrates pro-
vided a second fruitful approach for rescuing central apop-
totic genes. The rescue of ced-3 from 
 
Caenorhabditis ele-
gans 
 
and the identification of its mammalian homologues
as cysteine proteases (named caspases, more than 14
family members) established that a major arm of the
death-promoting pathways involves protease activation.
In mammals, the activation of the proteolytic activity can
be initiated by different mechanisms and at different intra-
cellular sites. One takes place at the receptor proximal
level through adaptor-mediated recruitment of the pro-
caspases to the death-inducing signaling complex named
DISC (e.g., by binding of pro-caspase 8 or 10 to FADD/
MORT-1 that in turn binds to Fas) (Kischkel et al., 1995;
Medema et al., 1997). A mitochondrial-based mechanism
involving ced-4 and ced-9 homologues (Apaf-1 and mem-
bers of the bcl-2 family, respectively) forms together with
cytochrome C another caspase-activating complex termed
the apoptosome (Green and Kroemer, 1998). These regu-
latory caspases function by cleaving the terminator cas-
pases. The spectrum of proteins that are cleaved by ter-
minator caspases is broad, including various structural
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1. 
 
Abbreviations used in this paper: 
 
D
 
CAM, deletion of calmodulin regula-
tory domain; CARD, caspase-recruiting domain; DAP, death-associated
protein; DD, death domain; DISC, death-inducing signaling complex;
DN-MORT/FADD, dominant negative mutant of MORT/FADD; GFP,
 
green fluorescent protein; ICE, interleukin 1
 
b
 
–converting enzyme; IFN-
 
g
 
,
 
interferon-
 
g
 
; PARP, poly (ADP–ribose) polymerase; TNF, tumor necrosis
factor; TNF-R, TNF-
 
a 
 
receptor. 
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proteins (e.g., nuclear lamins, Gas2, and gelsolin; Bran-
colini et al., 1995; Lazebnik et al., 1995; Kothakota et
al., 1997), as well as enzymes whose activity is regulated
directly or indirectly by the proteolytic cleavage (e.g.,
PAK2/PAK65 protein kinase, the PKC isoforms 
 
d
 
 and 
 
f
 
,
MEKK-1, PITSLRE protein kinase, and the endonuclease
CAD) (Cryns and Yuan, 1998; and references within). As
the multiplicity of mechanisms of caspase activation be-
comes apparent, it is becoming clear that membrane signals
formed by ligand–receptor interactions must diverge into
distinct biochemical pathways. These branches may each con-
tribute a distinct effect to the apoptotic phenotype or al-
ternatively may be redundant in their final cellular effects.
A functional approach to gene cloning, based on trans-
fections of HeLa cells with antisense cDNA libraries and
subsequent isolation of the fragments that protected cells
from interferon-
 
g
 
 (IFN-
 
g
 
)–induced cell death, initiated an
additional direction in the field (Deiss and Kimchi, 1991;
Deiss et al., 1995). This approach has recently led to the
identification of several novel proteins that are part of
the apoptotic pathways, called death-associated proteins
(DAPs) (for review see Kimchi, 1998). One of these iso-
lated proteins, DAP-kinase, identified as a calcium/cal-
modulin–regulated serine/threonine protein kinase, associ-
ated with actin microfilaments (Deiss et al., 1995; Cohen et
al., 1997). Its structure contains at least two additional do-
mains that might mediate interactions with other proteins
including ankyrin repeats and a typical death domain lo-
cated at the COOH-terminal part of the protein (Feinstein
et al., 1995). Overexpression of DAP-kinase in several cell
lines resulted in cell death and this death-promoting prop-
erty strictly depended on the intrinsic kinase activity. The
latter emerged from the finding that a constitutively active
kinase mutant, deleted of the calmodulin regulatory do-
main (
 
D
 
CaM), had stronger cell death effects than the
wild-type kinase, whereas a catalytically inactive mutant
(K42A) was not cytotoxic to cells (Cohen et al., 1997).
One of the surprising facets in the function of DAP-
kinase relates to its antimetastatic activity, recently ana-
lyzed in animal model systems (Inbal et al., 1997). This
feature was attributed to the finding that DAP-kinase con-
ferred sensitivity to apoptotic stimuli encountered by the
metastasizing cells, and opened a major question as to how
broad is the spectrum of apoptotic signals that depend on
DAP-kinase. In this work we focused specifically on apop-
totic responses that are triggered by two cytokines belong-
ing to the TNF family. We present several independent
lines of evidence indicating that DAP-kinase is involved in
cell death induced by TNF-
 
a
 
 and Fas. The importance of
the death domain in mediating the death-promoting func-
tion of DAP-kinase is documented here for the first time.
Finally, by transfection-based functional analyses it is
shown that DAP-kinase acts downstream to the DISC for-
mation (i.e., FADD/MORT1 and caspase 8) and upstream
of some other caspases, and that its death-promoting ef-
fects are counteracted by bcl-2.
 
Materials and Methods
 
Plasmids 
 
All expression plasmids used in this work were constructed in pcDNA3
 
vector (Invitrogen Corp.). Construction of wild-type DAP-kinase and
 
D
 
CaM mutant was described before (Cohen et al., 1997). DAPk/
 
D
 
DD and
 
D
 
CaM/
 
D
 
DD were constructed by truncation of wild-type and 
 
D
 
CaM DAP-
kinase, respectively, at the HindIII site, thus, deleting the 152–COOH-ter-
minal amino acids. DD-DAPk (amino acids 1,301–1,431), Flag-tagged at
the NH
 
2
 
 terminus, was constructed by PCR. The DD/L1337N mutation
was constructed by in vitro mutagenesis. Amino acid numbers in DAP-
kinase are according to Swissprot accession number P53355. The lu-
ciferase gene was subcloned into pcDNA3 from pGL3-luciferase (Promega),
and bcl-2 from pBluescript-bcl-2. The previously described MORT1 and its
dominant negative mutant (DN-MORT1), DN-Caspase-8 (also named
MACH
 
a
 
-C360S), p55-TNF-R, and p55/Fas chimera cloned into pcDNA3,
were used (Boldin et al., 1996). CrmA and p35 cDNAs were previously de-
scribed (Beidler et al., 1995; Tewari and Dixit, 1995). pEGFP-NI was pur-
chased from CLONTECH Laboratories (GFP, green fluorescent protein).
 
Cell Lines, Transfections, and Apoptotic Assays 
 
The HeLa human epithelial carcinoma cells, 293 human embryonic kidney
cells, and MCF7 human breast carcinoma cells were grown in DME (Bio-
logical Industries) with 10% FCS (Bio-Lab Scientific Ltd.). The HeLa-
tTA clone (Gossen and Bujard, 1992) was used for transient transfections
because of its high transfectability and the fact that it undergoes apoptotic
death in response to TNF-
 
a
 
 and cycloheximide. All cells for transient
transfection were seeded in a 6-well plate a day before transfection at den-
sity of 10
 
5
 
 cells/well. Transfections were done by the calcium–phosphate
method. For each well, we used a mixture containing 0.5 
 
m
 
g of cell death–
inducing plasmid (either p55-TNF-R, p55/Fas chimera, MORT1, or 
 
D
 
CaM
DAPk mutant), 1.5 
 
m
 
g of a plasmid to be tested for cell death protection
(DN-MORT, DN-Caspase-8, DD-DAPk, CrmA, p35, or luciferase as a
control), and 0.5 
 
m
 
g of GFP plasmid. Cells were counted and photo-
graphed 24 h after transfection. In each transfection four fields, each con-
sisting of at least 100 GFP-positive cells, were scored for apoptotic cells
according to their morphology. All the experiments were repeated at least
four times. When indicated, cell lysates were prepared from the transient
transfection at 24 h. For the experiments in Fig. 3 e, cells were transfected
solely with the DD-DAPk or DN-MORT and treated 24 h after transfec-
tion with human recombinant TNF-
 
a
 
 (30 ng/ml; R&D Systems, Inc.) and
cycloheximide (10 
 
m
 
g/ml) for 3 h. Stable transfections of HeLa cells and
neutral red dye uptake assays were done as previously described (Deiss
et al., 1995). Human recombinant IFN-
 
g
 
 (PeproTech) was added at 1,000
U/ml. For Fas killing of HeLa cells by agonistic antibodies, the cells were
pretreated for 24 h with 25 U/ml of IFN-
 
g
 
 (to increase Fas expression) and
exposed to 50 ng/ml of anti–Fas/APO-1 antibodies (IgG
 
3
 
; P.H. Krammer).
The percentage of viability was calculated as a fraction of the values mea-
sured in the absence of treatment. For poly (ADP–ribose) polymerase
(PARP) cleavage experiments, protein A (5 
 
m
 
g/ml; Sigma Chemical Co.)
was added concomitantly with the anti-Fas agonistic antibodies and cell
extracts were prepared after 4 h.
 
Immunoblot Analysis 
 
Western analysis was done as described before (Cohen et al., 1997) using
anti–DAP-kinase mAbs (1:2,000; Sigma Chemical Co.) or anti-PARP anti-
bodies (1:5,000; BIOMOL). For detection of Flag-tagged DD-DAPk, 4 
 
3
 
10
 
6
 
 cells were lysed in protein sample buffer and boiled. The clear superna-
tant was diluted eightfold with protein lysis buffer (Cohen et al., 1997) and 20
 
m
 
l of anti-Flag mAbs coupled to agarose beads (M2 affinity gel; IBI, Kodak)
were added for 3 h of incubation at 4
 
8
 
C. After three washes with protein lysis
buffer, proteins were eluted with sample buffer and boiled. Samples were an-
alyzed by 15% SDS-PAGE, transferred to nitrocellulose, and subjected to
Western blotting analysis with anti-Flag mAbs (1:200; IBI, Kodak).
 
Results
 
DAP-kinase Is Involved in FAS and
TNF-
 
a
 
–induced Apoptosis
 
The involvement of DAP-kinase in Fas-induced cell death
was first analyzed in HeLa cells, and compared in the same
assays to the well established involvement of DAP-kinase
in IFN-
 
g
 
 responses. For this purpose, a previously de-
scribed polyclonal population of HeLa cells, which stably 
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expresses high levels of DAP-kinase antisense RNA from
an Epstein-Barr virus-based vector (Deiss et al., 1995), was
used. As a control, we used another polyclonal population
of HeLa cells that was transfected with a nonrelevant vec-
tor carrying the dihydrofolate reductase gene (Deiss et al.,
1995). The viability of the cells was assessed using neutral
red dye uptake assay. The DHFR-transfected HeLa cells
were efficiently killed by IFN-
 
g
 
 as well as by the agonistic
antibodies against Fas/APO-1, which trigger Fas signaling
by inducing oligomerization of the receptors (Fig. 1 a). The
antisense DAP-kinase transfectants, however, displayed re-
duced cell death sensitivity to both IFN-
 
g
 
 and Fas signaling.
The extent of protection from IFN-
 
g
 
 and Fas-induced cell
death was similar and in both cases cell viability in treated
cultures remained 
 
z
 
50–55% (Fig. 1 a). The difference in
sensitivity between the two cell populations was also pro-
minent when PRAP cleavage, indicative of caspase activa-
tion, was measured in response to increasing concentrations
of the anti–Fas/APO-1 agonistic antibodies (Fig. 1 b). Thus,
a reduction in the levels of endogenous DAP-kinase pro-
tein by antisense RNA (Deiss et al., 1995) relieves not only
cell death responses to IFN-
 
g
 
, the feature that served as the
basis for the original selection, but also cell death responses
to Fas. This suggests that DAP-kinase may be a common
mediator in both cell death scenarios.
Another link between DAP-kinase and cytotoxic cyto-
kines was found in our lab by a set of experiments that un-
dertook an opposite approach. We reintroduced a DAP-
kinase expression construct into DAP-kinase null cells and
assayed whether it affected the cells’ sensitivity to TNF-
 
a
 
.
Expression of DAP-kinase enhanced the number of apop-
totic nuclei as compared with cells transfected with an
empty vector (Inbal et al., 1997). Thus, restoration of
DAP-kinase into cells that are DAP-kinase negative accel-
erated TNF-
 
a
 
–induced cell death.
 
The Death Domain Is Essential for the
Death-promoting Function of DAP-kinase and Displays 
Dominant Negative Features
 
To study the role of the death domain, it was first tested
whether its deletion may reduce the death-inducing func-
tions of DAP-kinase in transiently transfected 293 human
embryonic kidney cells. A constitutively active mutant of
DAP-kinase (
 
D
 
CaM) in which the catalytic activity is no
longer dependent on calcium/calmodulin was employed.
This gain-of-function mutant was previously shown to be
an effective inducer of cell death when transfected on its
own into cells (Cohen et al., 1997). To quantitate the num-
ber of apoptotic cells, we cotransfected the 
 
D
 
CaM mutant
with a vector expressing the GFP protein. The latter was
used as a marker to visualize the transfected cells and to
assess the apoptotic frequency among the transfectants ac-
cording to morphological alterations. Apoptotic cells were
scored after 24 h. Overexpression of the 
 
D
 
CaM mutant of
DAP-kinase resulted in massive apoptotic cell death (Fig.
2, a and d). Most of the GFP positive green cells rounded
up and shrunk, some of them showed cytoplasmic blebs,
and some were further fragmented into apoptotic bodies.
In contrast, when the cells were transfected with the
 
D
 
CaM mutant deleted of its death domain (Fig. 2 c,
 
D
 
CaM/
 
D
 
DD), apoptotic cells were much less abundant
(23% apoptotic cells compared with 68% in 
 
D
 
CaM trans-
fections; see Fig. 3 d). Similar results were obtained upon
transfections of these constructs into MCF7 human breast
carcinoma cells (data not shown). The two recombinant
proteins were expressed to comparable levels in these
transient transfection assays (Fig. 2 b). Deletion of the
death domain from the wild-type DAP-kinase, which as
expected is a less effective killer than the constitutively ac-
tive kinase, also reduced its ability to induce cell death
(14.5% apoptotic cells compared with 32% in DAP-kinase
transfections; Fig. 2 d). Therefore, it is concluded that the
death domain contributes to the death-inducing function
of DAP-kinase.
Since death domains of other known proteins were
shown to mediate protein–protein interactions, we postu-
lated that the death domain of DAP-kinase (DD-DAPk),
which contains all the functionally conserved regions
(Feinstein et al., 1995), may also be involved in interac-
tions with its specific partners, and, thus, may act in a dom-
inant negative manner. For that purpose, the death do-
Figure 1. DAP-kinase antisense RNA expression protects HeLa cells from Fas-induced cell death. (a) HeLa cells were stably trans-
fected with DAP kinase antisense cDNA fragment or with DHFR cDNA as a nonrelevant control. Viability was measured by neutral
red dye uptake assay and was calculated as described in Materials and Methods either after 40 h of exposure to anti–Fas/APO-1 agonis-
tic antibodies (50 ng/ml) or after 8 d of IFN-g treatment (1,000 U/ml). The results represent an average of three independent experi-
ments performed in quadruplet. (b) PARP cleavage analysis of the transfected HeLa cells treated with the indicated amount of anti–
Fas/APO-1 antibodies. The upper band is the 116-kD noncleaved PARP and the lower band is the typical 85-kD cleaved product. 
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main fragment (Fig. 2 c, DD-DAPk) was subcloned into
pcDNA3 expression vector. The DD-DAPk did not dis-
play any apoptotic activity when transfected into 293 cells
(Fig. 2, a and d), although expression was detectable in the
transiently transfected populations (Fig. 3 b). When the
DD-DAPk was cotransfected with the 
 
D
 
CaM mutant of
DAP-kinase it reduced significantly cell death induced by
DAP-kinase overexpression (Fig. 2 d). In contrast, a mu-
tant death domain (DD/L1337N), which carries a muta-
tion equivalent to the known inactivating 
 
lpr
 
 mutation in
the Fas receptor death domain, failed to inhibit cell death
induced by DAP-kinase (Fig. 2 d). Thus, the DD-DAPk
can be used as a dominant negative fragment that blocks
the action of the full-length protein, and, therefore, might
be suitable for checking the involvement of DAP-kinase in
cell death induced by TNF-
 
a
 
 or Fas.
 
The Death Domain of DAP-kinase Can Protect from 
TNF-
 
a
 
– and Fas-induced Cell Death
 
TNF-
 
a
 
– and Fas-induced cell death was triggered by over-
expressing the corresponding receptors in 293 and HeLa
cervical carcinoma cells in transient transfection assays.
Both cell lines express the endogenous DAP-kinase pro-
tein (Fig. 3 a). The receptor cDNAs were cotransfected
with the vector expressing the GFP protein. Transfection
of p55 TNF-R into 293 or HeLa cells resulted in massive
cell death by 24 h (Fig. 3 c). We also confirmed that the
observed cell death in these transient assays was caused by
p55 TNF-R activation, by using the previously described
dominant negative mutant of FADD/MORT-1 (called
DN-MORT or DN-FADD) that is deleted of its death ef-
fector domain (Boldin et al., 1995; Chinnaiyan et al.,
1995). DN-MORT abrogates the cytotoxic effects of the
Fas ligand or TNF-
 
a
 
 by preventing the endogenous adap-
tor protein from forming the signaling complexes at the re-
ceptor level (Chinnaiyan et al., 1996; Boldin et al., 1996).
Cotransfection of DN-MORT with p55 TNF-R inhibited
almost completely the induced cell death in 293 and HeLa
cells: 
 
z
 
90% of the transfected cells remained viable with
normal flat morphology, thus, confirming the specificity as
well as providing a positive death protective control in
these transient assays (Fig. 3 c).
The death assays showed that in 293 and HeLa cells, the
Figure 2. The death domain of
DAP-kinase is important for its
function in apoptosis. (a) Tran-
sient transfections of 293 cells
with  DCaM mutant, DCaM/DDD
mutant, or with the DD-DAPk.
Photographs were taken 24 h af-
ter transfection under fluores-
cent light microscope to visual-
ize GFP positive cells. (b)
Expression of DCaM and DCaM/
DDD mutants in the transiently
transfected 293 cells. Lane 1, ex-
pression of DCaM-DAPk; lane
2, expression of DCaM/DDD-
DAPk; and lane 3, endogenous
DAPk in cells transfected with a
nonrelevant vector. Western
blotting analysis was done with
anti–DAP-kinase antibodies. (c)
Schematic presentation of DAP-
kinase mutant proteins used in
these experiments. Kinase, ki-
nase domain; CaM, calmodulin
binding and regulatory domain;
ankyrin, ankyrin repeats; and
DD, death domain. Asterisks
delineate the region that by de-
letion mapping was shown to
be responsible for cytoskeletal
binding. (d) Transfections as
shown in a, with the indicated
constructs or double transfec-
tions of DCaM mutant with the
indicated constructs. The per-
centage of apoptotic cells was
calculated as described in Mate-
rials and Methods. 
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DD-DAPk inhibited TNF-induced cell death by 
 
z
 
50%
(Fig. 3 c). To further assess the specificity of DD-DAPk
inhibitory effect toward DAP-kinase, another cell line,
MCF7 breast carcinoma, was used in these transfections.
MCF7 cells were chosen since they do not express the en-
dogenous DAP-kinase gene (Fig. 3 a), consistent with pre-
vious data (Kissil et al., 1997). DD-DAPk had no protec-
tive effect on p55 TNF-R–induced cell death in MCF-7
cells (Fig. 3 c), in spite of the fact that it was efficiently ex-
pressed in these assays (Fig. 3 b) and in contrast to the
strong protection conveyed in these assays by DN-MORT.
DD-DAPk by itself had no cytotoxic effects in MCF7 cells
(data not shown), which is consistent with the results ob-
tained in 293 cells (Fig. 2). The lack of any death protec-
tive effect in DAP-kinase negative cells provides strong
evidence that DD-DAPk inhibits exclusively the function
of the endogenous DAP-kinase, indicating, again, that this
fragment can be used as a specific dominant negative mu-
tant for DAP-kinase.
We used the same method of cotransfections to investi-
gate the involvement of DAP-kinase in Fas-induced cell
death. For this purpose, we used a chimeric receptor com-
posed of the extracellular portion of TNF-R and the intra-
cellular portion of Fas, which was known to be more effec-
tive in inducing cell death by self oligomerization than
wild-type Fas receptors (Boldin et al., 1996). Its cotrans-
fection with GFP into 293 or HeLa cells resulted in 
 
z
 
80%
apoptotic cells among the GFP positive cells. Cotransfec-
tion with DN-MORT reduced cell death to 10% and
cotransfection with DD-DAP-kinase reduced cell death to
40% (Fig. 3 d). Again, DD-DAPk failed to protect the
MCF7 cells that do not express endogenous DAP-kinase
from Fas-induced cell death. Interestingly, the wild-type
Fas receptor, which by itself is a weak inducer of cell
death, when cotransfected with wild-type DAP-kinase
yielded strong death responses (data not shown).
Finally, in another type of assay, apoptosis was induced
by adding an external ligand (instead of receptor overex-
pression). To this aim, HeLa cells were treated with a
combination of TNF-
 
a
 
 and cycloheximide, which induced
apoptosis in these cells, at 24 h after transfection with DD-
DAPk, DN-MORT, or the luciferase control. DD-DAPk
reduced apoptotic cell death by 60% (Fig. 3 e) and DN-
MORT was more potent in reducing cell death. This assay
demonstrated again that DAP-kinase participates in TNF-
induced cell death. It also indicated that its function is not
dependent on de novo protein synthesis. Altogether, these
transient transfection assays provide additional support
for DAP-kinase being a positive mediator in both TNF-
 
a
 
–
and Fas-induced cell death.
Figure 3. Expression of DD-DAPk protects
from TNF-a– and Fas-induced cell death.
(a) Expression of endogenous DAP-kinase
in cell lines. Western blotting analysis of
extracts of indicated cells, using anti–DAP-
kinase antibodies. (b) Expression of recom-
binant DD-DAPk. Extracts from cells
transfected with DD-DAPk construct were
immunoprecipitated by anti-Flag antibodies
and analyzed by Western blotting using
anti-Flag. (c) Transient transfection of 293,
HeLa, or MCF7 cells with vectors encoding
p55-TNF-R, GFP, and either luciferase
(Luc), death domain of DAP-kinase (DD-
DAPk), or dominant negative mutant of
FADD/MORT1 (DN-MORT). The per-
centage of apoptotic cells was calculated as
described in Materials and Methods. (d)
Same as c, except that p55/Fas chimera was
used instead of p55-TNF-R. (e) Transient
transfection of HeLa cells with vectors en-
coding GFP and either luciferase, DD-
DAPk, or DN-MORT. Cells were treated
24 h after transfection with a combination of
TNF-a and cycloheximide. The number of
apoptotic cells was scored under fluorescent
microscopy 3 h after treatment. 
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Functional Position of DAP-kinase with Respect to the 
DISC formation, bcl-2, and Terminator Caspases
 
To place DAP-kinase along the apoptotic pathways of
TNF-
 
a
 
 and Fas, several known components of the system
were assayed in cotransfection assays. First the 293 cells
were transfected with a vector encoding the adaptor
protein–FADD/MORT1 that recruits proteins such as
caspase-8 to the vicinity of TNF-R and Fas. In agreement
with results from other laboratories (Boldin et al., 1995;
Chinnaiyan et al., 1995), overexpression of FADD/
MORT1 efficiently induced cell death. Cotransfection of
FADD/MORT1 with its previously mentioned dominant
negative mutant DN-MORT1, significantly reduced cell
death (Fig. 4 a). As expected, a dominant negative mutant
of caspase-8 (DN-Caspase-8), in which the cysteine in the
 
active site was substituted for serine (MACH
 
a
 
-C360S
in Boldin et al., 1996), reduced cell death induced by
MORT1. Interestingly, cotransfection of DD-DAPk to-
gether with FADD/MORT1 reduced very similarly the
number of apoptotic cells, thus, placing DAP-kinase down-
stream to MORT1.
The reciprocal approach was to test whether DN-MORT1,
DN-Caspase-8, or DD-DAPk could rescue death imposed
by 
 
D
 
CaM-DAPk overexpression. Both DN-MORT1 and
DN-Caspase-8 did not reduce cell death induced by acti-
vated DAP-kinase, whereas DD-DAPk served as a posi-
tive control to the experiment (Fig. 4 b). Thus, DAP-
kinase functions downstream to FADD/MORT1 as well
as to caspase-8, which are both recruited to the DISC
formed at the cytoplasmic portions of the TNF-R or Fas.
The inability of DN-MORT1, which is composed of the
death domain of MORT1, to protect from DAP-kinase–
induced death can serve as a control for specificity of over-
expressed death domains. To address pathways involving
mitochondria, the ability of bcl-2 to rescue death by acti-
vated DAP-kinase was tested. It was found that bcl-2 re-
duced death from 86 to 32% (Fig. 4 c), suggesting some
functional interaction with mitochondrial-based events.
Finally, the possibility that other caspases may function
as downstream mediators of DAP-kinase was tested by us-
ing two natural caspase inhibitors: CrmA, which is en-
coded by the cowpox virus genome; and p35, which is a
baculovirus encoded protein (for review see Villa et al.,
1997). These inhibitors were shown to inhibit the pro-
teolytic activity of several caspases and, as a consequence,
to block TNF-
 
a
 
– or Fas-induced cell death (Beidler et al.,
1995; Enari et al., 1995; Tewari and Dixit, 1995). Cotrans-
fection of the 
 
D
 
CaM mutant of DAP-kinase with either
one of these inhibitors decreased significantly cell death
(32% for CrmA, 26% for p35 compared with 86% without
inhibitors) (Fig. 4 c). These results functionally place some
members of the caspase family, probably other than
caspase-8, downstream to DAP-kinase, along pathway(s)
leading to cell death.
 
Discussion
 
The strategy of functional gene cloning, used for the res-
cue of DAP-kinase, was designed with the intention of iso-
lating genes that lie downstream to the IFN-
 
g
 
 early JAK/
STAT signaling and, therefore, probably common to vari-
ous apoptotic systems. This was achieved by introducing
an IFN-stimulated responsive element into the transcrip-
tion cassette that drives the antisense RNA expression.
The latter step in the construction of the antisense cDNA
library guaranteed that the selection will depend on intact
JAK/STAT signaling from IFN-
 
g
 
 receptors, thus, increasing
the probability of hitting genes that lie further downstream
(Deiss and Kimchi, 1991; Deiss et al., 1995). Indeed, the
present finding that DAP-kinase mediates TNF-
 
a
 
– and Fas-
induced cell death, strongly supports the notion that a cen-
tral death effector gene has been rescued, upon which
various types of receptor signaling cascades eventually
converge.
The involvement of DAP-kinase in TNF-
 
a
 
– and Fas-
induced cell death is supported here by several independent
lines of evidence. First, expression of the antisense RNA
Figure 4. Functional positioning of DAP-kinase along TNF/Fas
cell death pathways. Schematic representation of the results is
depicted above each bar graph. (a) Transient transfections of 293
cells with vectors encoding FADD/MORT1 together with vec-
tors encoding the indicated proteins. GFP plasmid is present in
each of the transfections. (b and c) Transfections as in a, except
that the DCaM mutant of DAP-kinase was used instead of
FADD/MORT1 together with vectors encoding the indicated
proteins. 
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fragment of DAP-kinase protected HeLa cells from Fas-
induced cell death (Fig. 1). Second, the death domain of
DAP-kinase (DD-DAPk) protected 293 human embry-
onic kidney cells as well as HeLa cells from apoptosis trig-
gered by overexpression of p55-TNF-R and Fas death re-
ceptors or by the TNF-
 
a
 
 ligand (Fig. 3). Also, the previous
data that restoration of DAP-kinase expression in D122
Lewis lung carcinoma cells, which do not express endoge-
nous DAP-kinase, accelerated significantly the appear-
ance of the apoptotic phenotype in response to TNF-
 
a
 
support this line (Inbal et al., 1997). Altogether, the data
suggest that DAP-kinase functions as a positive mediator
of these activated cytotoxic receptors belonging to the
TNF receptor family.
The assays involving transfections with DD-DAPk sup-
port for the first time the notion that this region of the pro-
tein displays dominant negative features. Moreover, dele-
tion of this region impaired the ability of DAP-kinase to
induce cell death. In the yeast two-hybrid system, the
death domain of DAP-kinase did not interact with itself
(Feinstein, E., and A. Kimchi, unpublished data), suggest-
ing that the death domain does not mediate homodimer-
ization of DAP-kinase. Therefore, this domain could po-
tentially mediate interactions with other proteins that are
critical for the function of DAP-kinase in cell death, the
nature of which is under current investigation.
The protection conveyed by the death domain of DAP-
kinase was always partial (
 
z
 
50%) and remained so even
when the amount of DNA used for the transient transfec-
tions were significantly increased (data not shown). The
effects of DD-DAPk were, therefore, clearly milder than
the effects of the DN-MORT obtained in the same assays.
This is not surprising considering the different functional
position along the death pathways of the two proteins.
FADD/MORT-1 acts in the proximity of Fas and TNF-
 
a
 
receptors and, therefore, DN-MORT mutant blocks early
receptor-generated events, such as the recruitment of
caspase-8 to the receptor complex. As a consequence, it
efficiently prevents most intracellular responses. DAP-
kinase, in contrast, is not part of the DISC, but rather
functions further downstream. The downstream position
with respect to the DISC was based on two lines of
evidence. One showed that DD-DAPk protected from
FADD/MORT1–induced cell death (Fig. 4 a). The other
illustrated that the death-promoting effect of the 
 
D
 
CaM
gain-of-function mutant of DAP-kinase was clearly resis-
tant to the dominant negative components of the DISC
(e.g., DN-MORT and DN-Caspase 8) (Fig. 4 b). Also,
when assayed by the yeast two-hybrid system, the death
domain of DAP-kinase did not bind to the death domain
of the Fas receptor (Feinstein, E., and A. Kimchi, un-
published data). Beyond the receptor complex, the death
pathways may diverge to several branches, and the partial
protections conveyed either by antisense DAP-kinase
RNA (Fig. 1) or by DD-DAPk (Fig. 3) imply that DAP-
kinase functions along some but not all these branches.
Also, the finding that DAP-kinase negative cell lines, such
as MCF7 or D122 (Inbal et al., 1997), can eventually be
killed by TNF-
 
a 
 
is consistent with the existence of DAP-
kinase–dependent and –independent branches.
Virally produced inhibitors of caspases were used to
show that members of the cysteine protease family are in-
volved in DAP-kinase–induced cell death. Among the two
inhibitors that were used, crmA is believed to be more
specific to the subfamily of the interleukin 1
 
b
 
–converting
enzyme (ICE)-like proteases, whereas p35 has a wider
spectrum (for review see Villa et al., 1997) In our experi-
ments, both inhibitors suppressed 
 
D
 
CaM-DAPk–induced
cell death to a similar extent. These results suggest that
ICE-like proteases mediate the effect of DAP-kinase. The
caspase family in general and the ICE-like subgroup in
particular include several proteases acting at different po-
sitions along death pathways. Therefore, it is hard to spec-
ulate, at the present time, about the specific proteases that
mediate the effect of DAP-kinase and their defined sub-
strates.
It is well established that the fast track of apoptosis
(comprising a direct cascade of caspase activation) is not
an exclusive pathway in the Fas-induced signaling (Scaffidi
et al., 1998). Mitochondrial-based events often provide a
second route for caspase activation and cell death in these
systems. In light of our findings that bcl-2 protected from
cell death induced by the 
 
DCaM-DAPk mutant, one possi-
bility is that DAP-kinase may be involved in one of these
mitochondrial pathways. Alternatively, since DAP-kinase
associates with the actin microfilament system (Cohen et al.,
1997), it might mediate signals converging into or emanat-
ing from the cytoskeleton. Should the protein substrates
that are directly phosphorylated by DAP-kinase be identi-
fied, then the detailed mechanisms coupling the kinase to
downstream targets may be deciphered. In any case, the
multidomain structure of this enzyme predicts the forma-
tion of multiprotein complex around DAP-kinase. Taken
together with its broad involvement in cell death induced
by several different triggers, DAP-kinase appears to be a
major player in apoptotic pathways.
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